Abstract
Cancer development involves multistep events. Therapeutic approaches can be targeted against any of these events individually or in combination. Pancreatic cancer can involve activation of Ki-Ras, overexpression of Myc or ErbB-2, and mutational inactivation of functional p53. Three approaches with nucleic acid-based therapies have been taken. A ribozyme specific for Ki-ras mRNA carrying the activating mutation in codon 12 (GGU to GUU) was designed and shown to be stimulated by interaction with an RNA-binding protein NCp7 of HIV-1. The same protein was targeted to cell-adhesion molecules, which allowed transfer of the ribozyme and an antisense oligodeoxynucleotide (ODN) into the cell. Furthermore, proliferation may be prevented by blocking signal transduction. A transdominant negative mutant of the signaling kinase c-Raf-1 efficiently blocked transmission. A retroviral vector will be used as carrier. Furthermore, the concept of using naked DNA injected intramuscularly as an immunogen against cancer is discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bartz C, Ziske C, Wiedenmann B. Moelling K (1996) p53 tumor suppressor gene expression in human pancreatic neuroendocrine carcinomas. GUT 38: 403–409
Blumer KJ, Johnson GL (1994) Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 19: 236–240
Bruder JT, Heidecker G, Rapp UR (1992) Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev 6: 545–556
Dannull J, Surovoy A, Jung G, Moelling K (1994) Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J 13: 1525–1533
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90: 11478–11482
Gruenewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, Janssen JW, Bartram CR (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43: 1037–1041
Hall PA, Lemoine NR (1993) Models of pancreatic cancer. Cancer Sury 16:135–155 Kolch W, Heidecker G, Lloyd P, Rapp UR (1991) Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349: 426–428
Markowitz D, Goff S, Bank A (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62: 1120–1124
Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980–990
Moodie SA, Wolfman A (1994) The 3Rs of life: Ras, Raf and growth regulation. Trends Genet 10: 44–48
Mueller G, Strack B, Dannull J, Sproat BS, Surovoy A, Jung G, Moelling K (1994) Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of Ki-ras ribozyme in vitro. J Mol Biol 242: 422–429
Paolella G, Sproat BS, Lamond A (1992) Nuclease resistant ribozymes with high catalytic activity. EMBO J 11: 1913–1919
Radziwill G, Niehof M, Rommel C, Moelling K (1995) Direct interaction and N-terminal phosphorylation of c-Jun by c-Mil/Raf. Proc Natl Acad Sci USA 92: 1421–1425
Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL (1991) Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A 88: 93–97
Tsuchihashi Z, Khosla M, Herschlag D (1993) Protein enhancement of hammerhead ribozyme catalysis. Science 262: 99–102
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749
Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB (1993) Gene inoculation generates immune responses against HIV-1. Proc Natl Acad Sci U S A 90: 4156–4160
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Moelling, K., Strack, B., Radziwill, G. (1996). Signal Transduction as Target of Gene Therapy. In: Kreuser, ED., Schlag, P.M. (eds) New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors. Recent Results in Cancer Research, vol 142. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80035-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-80035-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80037-5
Online ISBN: 978-3-642-80035-1
eBook Packages: Springer Book Archive